Clinical Trial Update: Autologous Bone Marrow Derived Stem Cells for Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating autologous bone marrow–derived stem cells for acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Autologous bone marrow-derived stem cells (bone marrow-derived stem cells)

Snippet

Sponsor: Royan Institute | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED